A role for endogenous transforming growth factor β1 in Langerhans cell biology: The skin of transforming growth factor β1 null mice is devoid of epidermal Langerhans cells

Journal of Experimental Medicine

Volumn 184, Issue 6, 1996, Pages 2417-2422

  Borkowski, Teresa A ^a   Letterio, John J ^a   Farr, Andrew G ^b   Udey, Mark C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; RAPAMYCIN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMIS CELL; FEMALE; LANGERHANS CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION; SURVIVAL; T LYMPHOCYTE;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; IMMUNOSUPPRESSIVE AGENTS; LANGERHANS CELLS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PHENOTYPE; POLYENES; SIROLIMUS; SKIN; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030456368     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.6.2417     Document Type: Article

References (30)

1. Sporn, M.B., and A.B. Roberts. 1992. Transforming growth factor-β: recent progress and new challenges. J. Cell. Biol. 119:1017-1021.
2. Kingsley, D.M. 1994. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes & Dev. 8:133-146.
3. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlovvski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature (Lond.). 359:693-699.
4. Kulkarni, A.B., C.-G. Huh, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, and S. Karlsson. 1993. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:770-774.
5. Dickson, M.C., J.S. Martin, F.M. Cousins, A.B. Kulkarni, S. Karlsson, and R.J. Akhurst. 1995. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development. 121:1845-1854.
6. Dang, H., A.G. Geiser, J.J. Letterio, T. Nakabayshi, L. Kong, G. Fernandas, and N. Talal. 1995. SLE-like autoantibodies and Sjogrens syndrome-like lymphoproliferation in TGFβ knockout mice. J. Immunol. 155:3205-3212.
7. Yaswen, L., A.B. Kulkarni, T. Fredrickson, B. Mittleman, R. Schiffmann, S. Payne, G. Longnecker, E. Moses, and S. Karlsson. 1996. Autoimmune manifestations in the transforming growth factor-β1 knockout mouse. Blood. 87:1439-1445.
8. Geiser, A.G., J.J. Letterio, A.B. Kulkarni, S. Karlsson, A.B. Roberts, and M.B. Sporn. 1993. Transforming growth factor β1 (TGF-β1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-β1 null mouse. Proc. Natl. Acad. Sci. USA. 90:9944-9948.
9. Vodovotz, Y., A.G. Geiser, L. Chesler, J.J. Letterio, A. Campbell, M.S. Lucia, M.B. Sporn, and A.B. Roberts. 1996. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor β1 null mouse. J. Exp. Med. 183:2337-2342.
10. Glick, A.B., A.B. Kulkarni, T. Tennebaum, H. Hennings, K.C. Flanders, M. O'Reilly, M.B. Sporn, S. Karlsson, and S.H. Yuspa. 1993. Loss of expression of transforming growth factor β in skin and skin tumors is associted with hyperproliferation and a high risk for malignant conversion. Proc. Natl. Acad. Sci. USA. 90:6076-6080.
11. Gruschwitz, M.S., and O.P. Hornstein. 1992. Expression of transforming growth factor type beta on human epidermal dendritic cells. J. Invest. Dermatol. 99:114-116.
12. Granucci, F., G. Girolomoni, M.B. Lutz, M. Foti, G. Marconi, P. Gnocchi, L. Nolli, and P. Ricciardi-Castagnoli. 1994. Modulation of cytokine expression in mouse dendritic cell clones. Eur. J. Immunol. 24:2522-2526.
13. Glick, A.B., M.M. Lee, N. Darwiche, A.B. Kulkarni, S. Karlsson, and S.H. Yuspa. 1994. Targeted deletion of the TGF-β1 gene causes rapid progression to squamous cell carcinoma. Genes & Dev. 8:2429-2440.
14. Caughman, S.W., S.O. Sharrow, S. Shimada, D. Stephany, T. Mizouchi, A. Rosenberg, S.I. Katz, and A. Singer. 1986. Ia+ murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex. Proc. Natl. Acad. Sci. USA. 83:7438-7442.
15. Farr, A., A. Nelson, J. Truex, and S. Hosier. 1991. Epithelial heterogeneity in the murine thymus: A cell surface glycoprotein expressed by subcapsular and medullary epithelium. J. Histochem. Cytochem. 39:645-653.
16. Holmes, K., and B.J. Fowlkes. 1991. Preparation of cells and reagents for flow cytometry. Curr. Prot. Immunol. 1:5.3.2-5.3.4.
17. Unkeless, J. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors J. Exp. Med. 150:580-596.
18. Tang, A., and M.C. Udey. 1991. Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation: ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells. J. Immunol. 146: 3347-3355.
19. Lee, M.-G., S.O. Sharrow, A.G. Farr, A. Singer, and M.C. Udey. 1994. Expression of the homophilic adhesion molecule E-cadherin by immature thymocytes and thymic epithelial cells. J. Immunol. 152:5653-5659.
20. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
21. Borkowski, T.A., A.J. Nelson, A.G. Farr, and M.C. Udey. 1996. Expression of gp40, the murine homolog of human epithelial adhesion molecule (Ep-CAM), by murine dendritic cells. Eur. J. Immunol. 26:110-114.
22. Kunz, J., and M.N. Hall. 1993. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. Trends Biochem. Sci. 18:334-338.
23. Witmer-Pack, M.D., D.A. Hughes, G. Schuler, L. Lawson, A. McWilliam, K. Inaba, R.M. Steinman, and S. Gordon. 1993. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J. Cell Sci. 104:1021-1029.
24. Christ, M., N.L. McCartney-Francis, A.B. Kulkarni, J.M. Ward, D.E. Mizel, C.L. Mackall, R.E. Gress, K.L. Hines, H. Tian, S. Karlsson, and S.M. Wahl. 1994. Immune dysregulation in TGF-β1-deficient mice. J. Immunol. 153:1936-1946.
25. + progenitors. J. Immunol. 157:1499-1507.
26. Keller, J.R., S.E.W. Jacobsen, K.T. Sill, L.R. Ellingsworth, and F.W. Ruscetti. 1991. Stimulation of granulopoiesis by transforming growth factor β: synergy with granulocyte/ macrophage-colony-stimulating factor. Proc. Natl. Acad. Sci. USA. 88:7190-7194.
27. Picker, L.J., J.R. Treer, B. Ferguson-Darnell, P.A. Collins, P.R. Bergstresser, and L.W.M.M. Terstappen. 1993. Control of lymphocyte recirculation in man II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J. Immunol. 150:1122-1136.
28. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.-P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multi-organ inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/ Rel family. Cell. 80:331-340.
29. Burkly, L., C. Hession, L. Ogata, C. Relly, L.A. Marconl, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature (Lond.). 373:531-536.
30. Arsura, M., M. Wu, and G.E. Sonenshein. 1996. TGF-β1 inhibits NF-κB/Rel activity inducing apoptosis of B cell: transcriptional activation of IκBα. Immunity. 5:31-40.